Yes, you can physically apply a TENS unit to the perineum or pelvic area, and small studies have tested this for erectile dysfunction (ED). However, TENS is not an approved or guideline-recommended ED treatment. Evidence is early-stage, mixed, and limited to small trials. It may help some men with nerve-related or pelvic-floor components of ED, but it should not replace proven therapies. Anyone considering it should talk to a clinician first, especially because correct electrode placement and underlying causes matter greatly.
How TENS is supposed to influence erection
A TENS unit delivers low-voltage electrical pulses through skin electrodes. These pulses mainly stimulate large sensory nerve fibers, which can dampen pain signals and alter local muscle tone and blood flow. The device does not directly create an erection. Instead, researchers hypothesize it may influence the nerves and muscles involved in the pelvic floor and the vascular events of erection.
An erection depends on a sequence: nerve signals trigger relaxation of smooth muscle in the penile arteries, blood flow increases, and the veins are compressed to trap blood. TENS placed on the perineum or dorsal penile nerve could, in theory, modulate the pudendal nerve pathways that carry these signals. Some studies also target pelvic-floor muscles, since a hypertonic or weak pelvic floor can interfere with erection quality. In plain terms, TENS is being tested as a way to nudge the nerve-muscle loop, not as a mechanical pump.
What the numbers actually show
The evidence base is thin. Most trials enroll 20 to 60 men, often without sham controls, and follow participants for only a few weeks. Reported outcomes vary widely. Some small studies of perineal or penile TENS report improvements in International Index of Erectile Function (IIEF) scores of roughly 2 to 6 points, which can be meaningful but is below the 4-point threshold often cited as the minimal clinically important difference. Others show no advantage over sham stimulation.
For context, phosphodiesterase-5 inhibitors like sildenafil produce IIEF improvements often in the 8 to 12 point range in responsive men. That gap matters: even positive TENS findings are modest by comparison. Success rates reported in these small trials range from about 30 percent to 60 percent, but without large randomized data these figures are unreliable. Treat any single percentage as provisional.
Where TENS might fit and where it fails
TENS is most plausible for men whose ED has a neuropathic or pelvic-floor component. Examples include nerve injury after prostate surgery, pelvic-floor dysfunction, or certain medication side effects. In these cases, electrical stimulation is being studied as an adjunct, not a cure.
It is least likely to help men with severe vascular disease, uncontrolled diabetes, or hormone deficiencies, where the underlying problem is blood supply or testosterone. If the arteries cannot dilate or the nerves are extensively damaged, surface stimulation will not fix the cause. A counterintuitive caveat: stronger stimulation is not better. Higher amplitude can cause muscle spasm or discomfort and may worsen pelvic-floor tension, the opposite of the intended effect.
Red-flag warnings before any use: Do not place electrodes on broken, infected, or numb skin. Avoid use if you have a pacemaker or implanted electrical device without cardiology clearance. Stop immediately for chest pain, dizziness, or skin burns. Do not use over the chest or neck; current can affect heart rhythm. Seek urgent care for priapism lasting more than 4 hours. Do not delay evaluation of new ED, which can signal heart disease or diabetes.
Common misconceptions
The biggest misconception is that TENS is a proven ED therapy. It is not. Major guidelines from urology societies do not list TENS among recommended treatments, and devices sold online are often marketed without regulatory clearance for ED.
Another myth is that any TENS placement works. Electrode position determines which nerves are stimulated, and incorrect placement can be ineffective or uncomfortable. A third is that TENS replaces medication or lifestyle change. In studies it is usually tested alongside standard care, and it cannot substitute for treating vascular risk factors.
Practical steps if you want to try it
First, get a diagnosis. Ask your clinician to assess vascular, hormonal, and neurologic causes before adding any device. Second, use only a TENS unit cleared by the FDA for pain or muscle stimulation; ED is not an approved indication, so you are using it off-label. Third, work with a physical therapist trained in pelvic-floor rehabilitation to confirm electrode placement and starting settings.
A reasonable trial protocol, based on published studies, is 20 to 30 minutes per session, several times weekly, for 4 to 6 weeks. Track IIEF-5 scores before and after rather than relying on impression. Stop if there is no measurable change by week 6. Keep total device spending modest; basic units cost roughly USD 30 to USD 100, and expensive "ED-specific" devices offer no proven extra benefit.
Comparison of ED options
| Option | Evidence strength | Typical effect | Main caveat |
|---|---|---|---|
| PDE5 inhibitors | High | Large IIEF gains | Side effects, contraindications |
| Vacuum erection device | Moderate-high | Reliable rigidity | Cumbersome, penile cooling |
| Pelvic-floor therapy | Moderate | Modest gains | Needs trained therapist |
| TENS (off-label) | Low | Small, inconsistent | Not guideline-approved |
| Lifestyle change | High | Gradual improvement | Takes months |
| Testosterone (if low) | High for deficiency | Variable | Only if diagnosed low |
Timeline of a typical TENS trial
| Week | Action | What to expect |
|---|---|---|
| 0 | Baseline IIEF-5, clinician review | Establish starting score |
| 1 | First sessions, 20 minutes | Learn placement, check skin |
| 2 | 3 to 5 sessions weekly | Early comfort adjustments |
| 3 | Continue, reassess | Possible subtle change |
| 4 | Midpoint IIEF-5 | Compare to baseline |
| 6 | Final IIEF-5 | Decide continue or stop |
| 8 | Clinician follow-up | Reassess underlying cause |
Limitations you should weigh
The honest limitation is that we lack large randomized trials. Most studies are small, short, and heterogeneous in electrode placement, frequency, and outcome measures. That makes firm conclusions impossible. TENS also addresses only nerve and muscle components, not arterial disease or hormones, so it cannot be a standalone solution.
Finally, sourcing matters. Claims should come from peer-reviewed trials and guidance from bodies such as the FDA and major urology societies, not from device sellers. If a product promises to "cure" ED, treat that as a warning sign. Use TENS, if at all, as a measured experiment under clinical supervision, with clear start and stop thresholds.